Back to rankings
Cooley LLP

Cooley LLP

Plus d'information

United States • Finance

1

Capital markets: equity offerings

Fielding a team of ‘incredibly experienced’ attorneys, Cooley LLP routinely advises issuers and managers on all aspects of equity offerings, predominantly focusing on high-profile IPOs and direct listings. The practice has extensive expertise across the biotech, biopharma, and healthcare industries, consistently acting on behalf of private and public companies alongside investment banks. Based out of San Diego, co-lead Charlie Kim is an expert in equity and debt issuances, primarily in the tech and consumer sectors, while in San Francisco, co-head David Peinsipp has expertise in follow-on and 144A offerings. From New York, Div Gupta is knowledgeable in IPOs on shares of common stock, and in Palo Alto, Eric Jensen specializes in capital markets and other corporate transactions, and Jon Avina assists tech companies with securities and governance proceedings. With the team also being well versed in proxy contests and acquisitions, Eric Jensen is a standout in New York, and West Coast’s John-Paul Motley is also highlighted as key.
L'éditorial du Legal 500

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

  • ‘Just an incredibly experienced team for IPO. An ability to understand clients' business which is exceptional that allows greater chance of IIPO success. Exceptional relationship with SEC.’

  • ‘Div & Ryan are fully dedicated to the company & always available. Their associates are high quality minimizing the risk of errors or lost time.’

  • ‘High motivation and commitment to client standards. Hustles with the best of them and want to deliver the best of the best, but also know how to have fun.’

  • ‘David Peinsipp knows all that you need to know about the law, but brings a fun energy that is rarely seen from many lawyers. Rachel Profitt is best known for her unique ability to connect with clients at a personal levee.’

  • ‘Very active across company and underwriter roles for private and public financings. Also, the team has significant experience in M&A transactions across the biopharma space. The firm size allows them to appropriately cover multiple demands with flexibility and expertise.’

  • ‘Working with Div Gupta, Rich Segal and Darah Protas, one can expect a high-level of professionalism and significant expertise. All three are consistently available to address matters in a timely manner, often anticipating needs before they arise.’

Points forts

Advised Rubrik on its upsized $752 million IPO of 23,500,000 shares of Class A common stock at a public offering price of $32 per share. This was the largest software IPO since 2021.
Advised Tempus AI on its $410 million IPO of 11,100,000 shares of Class A common stock at a public offering price of $37 per share.
Advised Life360 on its $178.5 million IPO of 6,612,500 shares of common stock at a public offering price of $27 per share.
Responsable de la pratique

Charlie Kim; David Peinsipp

Autres avocats clés

Div Gupta; Eric Jensen; Jon Avina; Eric Blanchard; John-Paul Motley; Christina Roupas; Marc Recht; Richard Segal; Kristin VanderPas; Jean Park; Denny Won; Peter Byrne; Milson Yu; Logan Tiari; Courtney Thorne; Darah Protas; Jonie Kondracki